Publikationen von Dietrich Falke
1. Falke D.
Virologie. In: Medizinische Mikrobiologie. 6. Auflage. Hahn H, Suerbaum S,
Kaufmann SHE, Schultz TH (Hrsg).
Springer Verlag, Heidelberg, 2008
2. Modrow S, Falke D, Truyen U, Schätzl H
Molekulare Virologie. 3. Aufl. Spektrum Akademischer Verlag, Heidelberg,
2008
3. Podlech J, Falke D
Virusinfektionen. In: Springer Lexikon Diagnose und Therapie. P. Reuter (Hrsg.).
Springer-Verlag, Heidelberg. 2006. p-1667-1678.
4. Keller KM, Braun R, Falke D.
Virusgastroenteritis. Differenzialdiagnose und Therapie.
tägl. prax. 2004:48:28-38
5. Hahn H, Falke D, Kaufmann SHE, Ullmann U.
Medizinische Mikrobiologie und Infektiologie. 5. Auflage
Springer Verlag, Heidelberg, 2004
6. Falke D, Podlech J.
Virus und Tumor – Grundbegriffe der Onkologie. In: Springer Lexikon Medizin.
P. Reuter (Hrsg.).
Springer-Verlag, Heidelberg. 2004.
7. Huemer HP, Wechselberger C, Bennett AM, Falke D, Harrington L.
Cloning and expression of the complement receptor glycoprotein C from
Herpesvirus simiae (herpes B virus): protection from complement-mediated cell
lysis.
J Gen Virol. 2003 May;84(Pt 5):1091-100.
8. Bachmann M, Deister H, Pautz A, Laubinger J, Schmitz M, Falke D,
Podlech J, Grölz D.
The human autoantigen La/SS-B accelerates herpes simplex virus type 1
replication in transfected mouse 3T3 cells.
Clin Exp Immunol. 1998 Jun;112(3):482-9.
9. Falke D.
Virologie am Krankenbett. Springer-Verlag, Heidelberg, 1998
10. Falke D.
Herpes simplex virus and the cytoskeleton.
Trends Microbiol. 1997 Aug;5(8):306.
11. Podlech J, Hengerer F, Fleck M, Kunkel J, Falke D.
Localization of latency-associated transcripts in the uterovaginal plexus of
herpes simplex virus type 1 and 2 latently infected mice.
J Gen Virol. 1997 May;78 ( Pt 5):1103-8.
12. Podlech J, Hengerer F, Fleck M, Eray K, Falke D.
Asymptomatical vaginal herpes simples virus infections in mice: virology and
pathohistology.
Arch. Virol. 1996; 141:263-74.
13. Podlech J, Hengerer F, Fleck M, Walev I, Falke D.
Replication of Herpes simplex virus type 1 and 2 in the medulla of the
adrenal gland after vaginal infection of mice.
Arch. Virol. 1996; 141:1999-2008.
14. Lingen M, Hengerer F, Falke D.
Mixed vaginal infections of Balb/c mice with low virulent herpes simplex
type 1 strains result in restoration of virulence properties: vaginitis/vulvitis
and neuroinvasiveness.
Med Microbiol Immunol. 1997 Mar;185(4):217-22.
15. Seck T, Koch O, Lingen M, Falke D.
Influence of glycoproteins B, C and D on the conversion of virus-to-cell
attachment from heparin sensitivity to resistance.
Acta Virol. 1996 Sep;40(4):179-85.
16. Klein SA, Dobmeyer JM, Dobmeyer TS, Falke D, Kabelitz D, Friese K,
Helm EB, Hoelzer D, Rossol-Voth R.
TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of
T-cell depletion in HIV infected individuals.
Eur J Med Res. 1996 Feb 22;1(5):249-58.
17. Lingen M, Seck T, Weise K, Falke D.
Two mutations in gB-1 and gD-1 of herpes simplex virus type 1 are involved
in the "fusion from without" phenotype in different cell types.
Virus Genes. 1996;13(3):221-8.
18. Podlech J, Hengerer F, Fleck M, Walev I, Falke D.
Replication of herpes simplex virus type 1 and 2 in the medulla of the
adrenal gland after vaginal infection of mice.
Arch Virol. 1996;141(10):1999-2008.
19. Lingen M, Seck T, Weise K, Falke D.
Single amino acid substitutions in the glycoprotein B carboxy terminus
influence the fusion from without property of herpes simplex virus type 1.
J Gen Virol. 1995 Jul;76 ( Pt 7):1843-9.
20. Lingen M, Seck T, Dehoust U, Weise K, Falke D.
Amino acid substitutions in glycoprotein D mediate the ability of fusion
from without-positive herpes simplex virus type 1 strains to penetrate at 4
degrees and in the presence of soluble glycoprotein D.
Intervirology. 1995;38(5):283-9.
21. Walev I, Podlech J, Falke D.
Enhancement by TNF-alpha of reactivation and replication of latent herpes
simplex virus from trigeminal ganglia of mice.
Arch Virol. 1995;140(6):987-92.
22. Walev I, Dienes HP, Bohl J, Podlech J, Falke D.
Correlation of virus replication, cytokine (TNF-alpha and IL-1) producing
cells, neuronal necrosis and inflammation after intranasal infection of mice
with herpes simplex virus strains of different virulence.
Arch Virol. 1995;140(11):1957-67.
23. Fleck M, Podlech J, Weise K, Falke D.
A vaccinia virus-herpes simplex virus (HSV) glycoprotein B1 recombinant or
an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and
protect against vaginal challenge in BALB/c mice.
Med Microbiol Immunol. 1994 May;183(2):87-94.
24. Walev I, Lingen M, Lazzaro M, Weise K, Falke D.
Cyclosporin A resistance of herpes simplex virus-induced "fusion from within"
as a phenotypical marker of mutations in the Syn 3 locus of the glycoprotein B
gene.
Virus Genes. 1994 Jan;8(1):83-6.
25. Seck T, Lingen M, Weise K, Falke D.
Evidence for a multistep mechanism for cell-cell fusion by herpes simplex
virus with mutations in the syn 3 locus using heparin derivatives during fusion
from within.
Arch Virol. 1994;136(1-2):173-81.
26. Dienes HP, Schirmacher P, Weise K, Falke D.
Herpes simplex virus hepatitis and related problems.
Int Rev Exp Pathol. 1994;35:1-38. Review.
27. Falke D.
[Milestones in virology]
Immun Infekt. 1993 Jun;21(3):69-74. Review. German.
28. Buchele A, Scholz U, Haferkamp A, Falke D, Eger K.
Affinitätschromatographie. Proteinreinigung und Enzymreinigung.
BioTec. 1993.; 6:36-39
29. Fleck M, Podlech J, Weise K, Müntefering H, Falke D.
Pathogenesis of HSV-1/2 induced vaginitis/vulvitis of the mouse: dependence
of lesions on genetic properties of the virus and analysis of pathohistology.
Arch Virol. 1993;129(1-4):35-51.
30. Wollert KC, Fleck M, Podlech J, Weise K, Corell A, Falke D.
Vaginal infection of mice with HSV type 2 variant ER-: a new animal model
for human primary genital HSV type 2 infections.
J Virol Methods. 1992 Mar;36(3):265-76.
31. Bachmann M, Althoff H, Tröster H, Selenka C, Falke D, Müller WE.
Translocation of the nuclear autoantigen La to the cell surface of herpes
simplex virus type 1 infected cells.
Autoimmunity. 1992;12(1):37-45.
32. Huemer HP, Larcher C, Dierich MP, Falke D.
Factors influencing the interaction of herpes simplex virus glycoprotein C
with the third component of complement.
Arch Virol. 1992;127(1-4):291-303.
33. Walev I, Kunkel J, Schwaeble W, Weise K, Falke D.
Relationship between HLA I surface expression and different cytopathic
effects produced after herpes simplex virus infection in vitro.
Arch Virol. 1992;126(1-4):303-11.
34. Gosztonyi G, Falke D, Ludwig H.
Axonal-transsynaptic spread as the basic pathogenetic mechanism in B virus
infection of the nervous system.
J Med Primatol. 1992 Jan;21(1):42-3.
35. Gosztonyi G, Falke D, Ludwig H.
Axonal and transsynaptic (transneuronal) spread of Herpesvirus simiae (B
virus) in experimentally infected mice.
Histol Histopathol. 1992 Jan;7(1):63-74.
36. Friese K, Beichert M, Hof H, Weikel W, Falke D, Sickinger R, Melchert
F.
[Incidence of congenital infections]
Geburtshilfe Frauenheilkd. 1991 Nov;51(11):890-6. German.
37. Walev I, Weise K, Falke D.
Differentiation of herpes simplex virus-induced fusion from without and
fusion from within by cyclosporin A and compound 48/80.
J Gen Virol. 1991 Jun;72 ( Pt 6):1377-82.
38. Wiegand H, Dienes HP, Schirmacher P, Podlech J, Bohl K, Bohle M,
Neumann-Haefelin D, Falke D.
Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and
2.
II. Histopathological, immunohistochemical and in situ hybridization studies.
Arch Virol. 1991;117(3-4):237-49.
39. Walev I, Wollert KC, Weise K, Falke D.
Characterization of fusion from without induced by herpes simplex virus.
Arch Virol. 1991;117(1-2):29-44.
40. Wollert K, el Ansari T, Rösen-Wolff A, Falke D.
The region 0.7615-0.796 m.u. of the HSV-1 genome determines suppression of
humoral antibody formation against herpes simplex virus.
Arch Virol. 1991;116(1-4):175-84.
41. Rossol-Voth R, Rossol S, Schütt KH, Corridori S, de Cian W, Falke D.
In vivo protective effect of tumour necrosis factor alpha against
experimental infection with herpes simplex virus type 1.
J Gen Virol. 1991 Jan;72 ( Pt 1):143-7.
42. Keller KM, Bambauer C, Wirth S, Queisser-Luft A, Falke D, Baumann W.
[Hepatitis A, B, CMV, EBV and HIV infections in premature and term newborn
infants following polytransfusion]
Monatsschr Kinderheilkd. 1990 Sep;138(9):611-4. German.
43. Podlech J, Weise K, Falke D.
Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I.
Virological studies.
Arch Virol. 1990;110(3-4):165-77.
44. Falke D, Weise K, Wollert K.
Die Chemotherapie von Virusinfektionen.
Akademie für Ärztliche Fortbildung Rheinland-Pfalz. Fortbildungsbeitrag Nr. 163.
ÄRP 43. 1990:197-202.
45. Bachmann M, Falke D, Müller WE.
Is La protein involved in autoimmunization and inflammatory events during
disease? Characterization of La protein as an unwinding enzyme.
Mol Biol Rep. 1990;14(2-3):49-50.
46. Schröder HC, Falke D, Weise K, Bachmann M, Carmo-Fonseca M, Zaubitzer
T, Müller WE.
Change of processing and nucleocytoplasmic transport of mRNA in
HSV-1-infected cells.
Virus Res. 1989 May;13(1):61-78.
47. Bachmann M, Falke D, Schröder HC, Müller WE.
Intracellular distribution of the La antigen in CV-1 cells after herpes
simplex virus type 1 infection compared with the localization of U small nuclear
ribonucleoprotein particles.
J Gen Virol. 1989 Apr;70 ( Pt 4):881-91.
48. Schirmacher P, Wörsdörfer M, Lübbe K, Falke D, Thoenes W, Dienes HP.
HSV hepatitis in the mouse: a light and electron microscopic study with
immunohistology and in situ hybridization.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56(6):351-61.
49. Bachmann M, Schröder HC, Falke D, Müller WE.
Alteration of the intracellular localization of the La protein compared with
the localization of U snRNPs.
Cell Biol Int Rep. 1988 Sep;12(9):765-89.
50. Falke D, Müntefering H, Stallmach D.
[Is type I diabetes a virus-induced disease?]
Wien Klin Wochenschr. 1988 Jun 24;100(13):422-30. Review. German.
51. Huemer HP, Menzel HJ, Potratz D, Brake B, Falke D, Utermann G, Dierich
MP.
Herpes simplex virus binds to human serum lipoprotein.
Intervirology. 1988;29(2):68-76.
52. Metzger B, Podlech J, Müller S, Falke D.
Suppression of humoral immune response against herpes simplex virus induced
by
defective strains, ts- and TK- mutants.
Arch Virol. 1988;99(3-4):143-52.
53. Nick S, Metzger B, Muller S, Falke D.
Virus-specific IgM and IgG antibody production by B cells during herpes
simplex virus type 2-induced immunosuppression as analysed by an immunospot
assay.
J Gen Virol. 1987 Jul;68 ( Pt 7):1951-9.
54. Nick S, Metzger B, Jonsić S, Falke D.
Suppression of humoral antibody formation against sheep red blood cells by
infections with HSV-2 and the influence of mouse cytomegalovirus. Brief report.
Arch Virol. 1987;97(1-2):131-5.
55. Dienes HP, Hiller G, Müller S, Falke D.
Microtubules and intermediate filaments of herpes simplex virus infected
cells.
Arch Virol. 1987;94(1-2):15-28.
56. Falke D, Müller, S.
Diagnostik und Differentialdiagnose der Virusinfektionen für die
klinisch-praktische Medizin (1).
Internist. Prax. 1987:27:95-104
57. Falke D, Müller, S.
Diagnostik und Differentialdiagnose der Virusinfektionen für die
klinisch-praktische Medizin (2).
Internist. Prax. 1987:27:279-92
58. Callensee W, Falke D.
Atypische Verläufe von Varicella-Zoster-Infektionen.
Internist. Prax. 1987:36:507-20
59. Bachmann M, Falke D, Preuhs J, Schröder HC, Pfeifer K, Müller WE.
Occurrence of novel small RNAs with concomitant inhibition of host cellular
U small nuclear RNA synthesis in Vero cells infected with herpes simplex virus
type 1.
J Gen Virol. 1986 Dec;67 ( Pt 12):2587-94.
60. Nick S, Kampe P, Knoblich A, Metzger B, Falke D.
Suppression and enhancement of humoral antibody formation by herpes simplex
virus types 1 and 2.
J Gen Virol. 1986 Jun;67 ( Pt 6):1015-24.
61. Heeg U, Dienes HP, Müller S, Falke D.
Involvement of actin-containing microfilaments in HSV-induced cytopathology
and the influence of inhibitors of glycosylation.
Arch Virol. 1986;91(3-4):257-70.
62. Potratz D, Brake B, Dienes HP, Schulz TF, Hosp M, Dierich MP, Falke D.
Herpes simplex virus type 1 and 2 in the adrenal glands: replication and
histopathology.
Arch Virol. 1986;90(3-4):207-22.
63. Falke D, Knoblich A, Gerken G.
Pathogenesis and Diagnosis of HSV-Induced Diseases. (C. Simon, P. Wilkinson,
eds). In: Diagnosis of Infectious Diseases – New Aspects. Schattauer Verlag.
1986, p. 275-284.
64. Kampe P, Knoblich A, Dietrich M, Falke D.
Differences in humoral immunogenicity between herpes simplex virus types 1
and 2.
J Gen Virol. 1985 Oct;66 ( Pt 10):2215-23.
65. Gerken G, Trautmann F, Köhler H, Falke D, Bohl J, Nix W, Meyer zum
Büschenfelde KH.
Rare association of herpes simplex virus IgM-specific antibodies and
Guillain-Barré syndrome successfully treated with plasma exchange and
immunosuppression.
Klin Wochenschr. 1985 May 15;63(10):468-74.
66. Falke D, Knoblich A, Müller S.
Fusion from without induced by herpes simplex virus type 1.
Intervirology. 1985;24(4):211-9.
67. Dienes HP, Knoblich A, Falke D.
Loss of surface fibronectin after infection of cultured cells by HSV-1 and
2.
Arch Virol. 1985;86(3-4):223-37.
68. Knoblich A, Müller WE, Harle-Grupp V, Falke D.
Enhancement of antibody formation against herpes simplex virus in mice by
the T-cell mitogen bestatin.
J Gen Virol. 1984 Oct;65 ( Pt 10):1675-86.
69. Ramadori G, Dienes HP, Meyer zum Büschenfelde KH, Falke D.
Infection of murine hepatocyte cultures by herpes simplex virus (HSV) 1 and
2.
Liver. 1984 Oct;4(5):318-24.
70. Görtz J, Brake B, Härle-Grupp V, Falke D.
Replication of HSV-1 in murine peritoneal macrophages: comparison of various
virus strains with different properties.
Arch Virol. 1984;79(3-4):173-87.
71. Labenz J, Müller WE, Falke D.
Inhibition of the herpes simplex virus-coded thymidine kinase-complex by
9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) and
9-(2-hydroxyethoxy-methyl)guanine-monophosphate (acyclo-GMP).
Arch Virol. 1984;81(3-4):205-12.
72. Dienes HP, Ramadori G, Falke D, Thoenes W.
Electron microscopic observations on primary hepatocyte cultures infected
with herpes simplex virus types I and II.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;46(4):321-32.
73. Falke D, Knoblich A, Ackermann R.
Röteln-Epidemie in Rheinland-Pfalz..
Akademie für Ärztliche Fortbildung Rheinland-Pfalz.
ÄRP 8. 1984:492-497.
74. Görtz J, Brake B, Härle-Grupp V, Falke D.
Replication of HSV-1 in murine peritoneal macrophages: Comparison of various
virus strains with different properties.
Arch. Virol. 1984:79:173-87
75. Leyhausen G, Schuster DK, Vaith P, Zahn RK, Umezawa H, Falke D, Müller
WEG.
Identification and properties of the cell membrane bound leucine
aminopeptidase interacting with the potential immunostimulant and
chemotherapeutic agent bestatin.
Biochem Pharmacol. 1983 Mar 15;32(6):1051-7.
76. Labenz J, Friedrich D, Müller WEG, Falke D.
Adenosine- and ADP-phosphorylating capacity of herpes simplex virus-induced
thymidine kinase enzyme complex.
Intervirology. 1983;19(2):77-84.
77. Knoblich A, Görtz J, Härle-Grupp V, Falke D.
Kinetics and genetics of herpes simplex virus-induced antibody formation in
mice.
Infect Immun. 1983 Jan;39(1):15-23.
78. Falke D, Labenz J, Brauer D, Müller WEG.
Adenosine diphosphate: thymidine 5'-phosphotransferase, a new enzyme
activity, associated with the Herpes simplex virus-induced deoxypyrimidine
kinase.
Biochim Biophys Acta. 1982 Oct 20;708(1):99-103.
79. Schneider D, Brauer D, Falke D.
Alkaline phosphodiesterase I and alkaline phosphatase I in plasma membranes
of herpes simplex virus type 1 transformed hamster cells.
Biochim Biophys Acta. 1982 Feb 8;685(1):94-104.
80. Müller WEG, Schuster DK, Zahn RK, Maidhof A, Leyhausen G, Falke D,
Koren R, Umezawa H.
Properties and specificity of binding sites for the immunomodulator bestatin
on the surface of mammalian cells.
Int J Immunopharmacol. 1982;4(5):393-400.
81. Labenz J, Friedrich D, Falke D.
Analysis of the TK enzyme complex induced by HSV types 1 and 2 by means of
isoelectric focusing and polyacrylamide gel electrophoresis.
Arch Virol. 1982;71(3):235-49.
82. Müller WEG, Falke D.
The DNA replication system of Herpes viruses: A target for
chemotherapeutics.
Medical Virology. 1982:327-359
83. Falke D, Nehrbass W, Brauer D, Müller WEG.
Adenylic acid: deoxythymidine 5'-phosphotransferase: evidence for the
existence of a novel herpes simplex virus-induced enzyme.
J Gen Virol. 1981 Apr;53(Pt 2):247-55.
84. Müller WEG, Zahn RK, Arendes J, Schröder HC, Falke D.
DNA-replication complex from cells infected with herpes virus.
Eur J Biochem. 1981 Mar 16;115(1):159-67.
85. Heeg U, Haase W, Brauer D, Falke D.
Microtubules and microfilaments in HSV-Infected rabbit-kidney cells.
Arch Virol. 1981;70(3):233-46.
86. Falke D.
Neue Erkenntnisse der Virologie für die klinisch-praktische Medizin.
Akademie für Ärztliche Fortbildung Rheinland-Pfalz.
Fortbildungsbeitrag Nr. 69, ÄRP 10. 1981:793-806.
87. Schneider D, Falke D.
Investigations on the mechanism of induction of the alkaline phosphatase by
bromo-desoxyuridine in herpes simplex virus transformed cells and the transport
of uridine.
Z Naturforsch [C]. 1980 Nov-Dec;35(11-12):1036-45.
88. Zöllner EJ, Zahn RK, Falke D.
Deoxyribonucleases in herpes simplex virus type 1 and 2 infected primary
rabbit kidney cells.
Z Naturforsch [C]. 1980 Sep-Oct;35(9-10):747-9.
89. Caspary L, Schindling B, Dundarov S, Falke D.
Infections of susceptible and resistant mouse strains with herpes simplex
virus type 1 and 2.
Arch Virol. 1980;65(3-4):219-27.
90. Falke D, Dundaroff S, Nehrbass W, Schröder R, Müller WEG.
The pathway of thymidine from the cell membrane to virus DNA:
phosphorylation by thymidine-kinase and AMP-dThd phosphotransferase in cells
infected with Herpes simples virus. Coller LH, Oxford J, eds. In: Developments
in Antiviral Therapy.
Academic Press. 1980; p. 2-20
91. Müller WEG, Falke D, Zahn RK, Arendes J.
Ribonuclease H levels in herpes simplex virus-infected cells.
Arch Virol. 1980;64(3):269-75.
92. Müller WEG, Zahn RK, Arendes J, Falke D.
Oligoribonucleotide initiators for herpes simplex virus DNA synthesis in
vivo and in vitro.
Virology. 1979 Oct 15;98(1):200-10.
93. Dierich MP, Landen B, Schulz T, Falke D.
Protease activity on the surface of HSV-infected cells.
J Gen Virol. 1979 Oct;45(1):241-4.
94. Falke D, Ronge K, Arendes J, Müller WEG.
Differential and selective inhibition of cellular and herpes simplex virus
DNA synthesis by arabinofuranosyladenine.
Biochim Biophys Acta. 1979 Jun 20;563(1):36-45.
95. Müller WEG, Zahn RK, Arendes F, Falke D.
Phosphorylation of arabinofuranosylthymine in non-infected and herpesvirus
(TK+ and TK-)-infected cells.
J Gen Virol. 1979 May;43(2):261-71.
96. Falke D, Moser H, Link D, Müller WEG.
The effect of 1-beta-D-arabinofuranosylthymine on the growth of herpes
simplex
virus types 1 and 2.
J Gen Virol. 1979 Feb;42(2):435-8.
97. Röllinghoff M, Pfizenmaier K, Falke D, Wagner H.
T cell-mediated cytotoxic immune response to HSV infection and its
modification due to antimetabolites.
Adv Ophthalmol. 1979;38:247-54.
98. Falke D, Moser H, Link D, Müller WEG.
The effects of alpha- and beta-D-arabinosyladenosine and beta-D-arabinosylthymine
on the synthesis of HSV types 1- and 2-infected cells.
Adv Ophthalmol. 1979;38:197-203.
99. Müller WEG, Falke D.
Cellular and herpesvirus polymerases: their significance for chemotherapy.
Adv Ophthalmol. 1979;38:187-96.
100. Müller WEG, Falke D, Zahn RK, Arendes J.
Poly(adenosine diphosphate ribose) synthesis during herpes simplex virus
infection.
Intervirology. 1979;11(3):182-7.
101. Schneider D, Falke D.
Fucose-Containing Glycoproteins from Cell Surface Membrane of Hamster Cells
Transformed by Herpes simplex Virus (Type I): Isolation and Some Molecular
Properties of a Membrane Glycoprotein with Alkaline Phosphatase Activity.
Glycoconjugate Research. Volume II. Proceedings of the Fourth International
Symposium on Glycoconjugates.1979, p.1077-80
102. Müller WEG, Falke D, Zahn RK, Arendes J.
Alterations of polyadenylate nuclease activities in herpes simplex
virus-infected
cells.
Virology. 1978 Jun 1;87(1):89-95.
103. Frank U, Schindling B, Lindermann J, Falke D.
Multiplication of herpes simplex virus types 1 and 2 in macrophages of NMRI
and C57/BL mice.
Acta Virol. 1978 May;22(3):193-202.
104. Müller WEG, Zahn RK, Falke D.
Variation of DNA polymerase and RNA polymerase activities in cells infected
with
herpes simplex virus type 1.
Virology. 1978 Feb;84(2):320-30.
105. Falke D.
[Cell transformation by viruses and the development of tumours (author's
transl)]
Immun Infekt. 1978 Feb;6(1):5-14. German.
106. Frank U, Caspary L, Hahn H, Falke D.
The effect of dextransulfate 500 on the pathogenesis of herpes simplex virus
infections in weanling mice.
Arch Virol. 1978;58(4):259-68.
107. Moser H, Schneider D, Falke D.
Influence of Concanavalin A on protein synthesis and protein release in BHK
21 cells.
Biochim Biophys Acta. 1978;507:445-58.
108. Dundarov S, Dundarova D, Todorov S, Kavaklova L, Falke D.
Induction capacity and influence of dThdMP on thymidine kinase activity of
type 1 and 2 strains of herpes simplex virus.
Arch Virol. 1978;56(3):243-9.
109. Bittlingmaier K, Schneider D, Falke D.
Influence of dibutyryl cyclic AMP on thymidine uptake by herpes simplex
virus infected cells and the intracellular level of cyclic AMP.
Biochim Biophys Acta. 1977 Aug 2;477(3):228-38.
110. Bittlingmaier K, Schneider D, Falke D.
Thymidine transport in herpesvirus hominis type 1 and 2 infected BHK 21
cells.
J Gen Virol. 1977 Apr;35(1):159-73.
111. Falke D.
Virologie. 2 Auflage.
Springer-Verlag, Heidelberg. 1977.
112. Falke D.
Virologia. 2 Auflage. (in portugiesischer Sprache)
Springer-Verlag, Heidelberg. 1977.
113. Müller WE, Zahn RK, Bittlingmaier K, Falke D.
Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine
in
cellular and cell-free systems.
Ann N Y Acad Sci. 1977 Mar 4;284:34-48.
114. Pfizenmaier K, Starzinski-Powitz A, Röllinghoff M, Falke D, Wagner H.
T-cell-mediated cytotoxicity against herpes simplex virus-infected target
cells.
Nature. 1977;265:630-32.
115. Müller WEG, Zahn RK, Beyer R, Falke D.
9-beta-D-Arabinofuranosyladenine as a tool to study herpes simplex virus DNA
replication in vitro.
Virology. 1977 Feb;76(2):787-96.
116. Just I, Dundaroff S, Falke D.
Biochemical classification of herpes simplex virus types 1 and 2, and of
intermediate strains on the basis of different susceptibilities of thymidine
kinase to thymidine analogues.
Acta Virol. 1976 Feb;20(1):31-9.
117. Bittlingmaier K, Schneider D, Falke D.
Uptake of [3H] thymidine and cell DNA synthesis during the early
multiplication phase of herpesvirus hominis in BHK cells.
Biochim Biophys Acta. 1975 Nov 4;407(4):384-91.
118. Just I, Dundaroff S, Falke D, Wolf HU.
Regulation by thymidine monophosphate and other nucleotides of thymidine
kinase activity in extracts from primary rabbit kidney cells infected by HSV
types 1 and 2.
J Gen Virol. 1975 Oct;29(1):69-80.
119. Falke D, Lemmel EM, Richardson LS, Wolf HU.
Enhancement of phagocytosis by Compound 48/80 and its influence upon
Ca++-dependent ATP-ase.
Arzneimittelforschung. 1975 Aug;25(8):1258-61.
120. Dundaroff S, Just I, Falke D.
Influence of double infections on the induction of thymidine kinase by
UV-irradiated herpes simplex virus types 1 and 2 and pseudorabies virus.
Arch Virol. 1975;49(2-3):117-26.
121. Falke D.
[Epidemiology of varicella-zoster-virus and of herpesvirus hominis (author's
transl)]
Immun Infekt. 1974 Oct;2(4):183-8. German.
122. Schneider D, Moser H, Falke D.
Proceedings: Influence of concanavalin A on nucleic acid and protein
synthesis in
growing baby hamster kidney-21 cells.
Hoppe Seylers Z Physiol Chem. 1974 Oct;355(10):1251-2.
123. Steinbach PD, Rockert H, Kohlhoff-Funke A, Falke D, Wigand R.
[Contagious kerato-conjunctivitis in the Mainz area (author's transl)]
Klin Monatsbl Augenheilkd. 1974 Mar;164(3):334-9. German.
124. Richter IE, Falke D.
Scanning electron microscopic observations on the inhibition of
herpes-induced giant cell formation by CPD 48-80 and Cytochalasin B.
Pathol Eur. 1974;9(1):59-73.
125. Just I, Falke D.
Inhibition of giant cell formation by Compound 48-80 after infection with
herpesvirus hominis. IV. Compound 48-80, an inhibitor of choline kinase
activity.
Arch Gesamte Virusforsch. 1974;46(1-2):140-7.
126. Falke D, Just I, Strecker W.
Inhibition of giant cell formation by Compound 48-80 after infection with
herpesvirus hominis. III. Binding of tritium-labelled Compound 48-80 to normal
and infected cells and its action upon phosphatidyl-choline-biosynthesis.
Arch Gesamte Virusforsch. 1974;46(1-2):127-39.
127. Just I, Schneider D, Falke D.
[A biochemical differentiation of thymidine kinase induced by type 1 and 2
herpesvirus]
Zentralbl Bakteriol [Orig A]. 1974;227(1-4):339-44. German.
128. Müller WEG, Falke D, Zahn RK.
DNA-dependent DNA polymerase pattern in noninfected and herpesvirus infected
rabbit kidney cells.
Arch Gesamte Virusforsch. 1973;42(3):278-84.
129. Müller WEG, Falke D, Heicke B, Zahn RK.
Biological activity of 2-phenylethanol and its derivatives. 8. Influence on
herpesvirus DNA-synthesis in rabbit kidney cells.
Arch Gesamte Virusforsch. 1973;40(3):205-14.
130. Falke D.
[Membrane alterations in virus-infected cells]
Arzneimittelforschung. 1972 Dec;22(12):2040-3. German.
131. Dundaroff S, Falke D.
Thymidine-, uridine- and choline-kinase in rabbit kidney cells infected with
herpesvirus hominis, type I and II.
Arch Gesamte Virusforsch. 1972;38(1):56-66.
132. Falke D, Heicke B, Bässler R.
The effect of arabinofuranosyl-cytosine upon the synthesis of Herpesvirus
hominis.
Arch Gesamte Virusforsch. 1972;39(1):48-62.
133. Falke D.
[The origin of virus neoplasms. An example for the changing of the infection
concept]
Dtsch Med Wochenschr. 1971 Jul 2;96(27):1167-72. German.
134. Falke D, Kahl GF.
The inhibitory effect of compound 48-80 on the formation of giant cells
induced by herpesvirus hominis.
J Gen Virol. 1971 Mar;10(3):273-7. No abstract available.
135. Clauss I, Falke D.
[Immune adherence for demonstration of virus specific antigens and
antibodies. 3. Studies on the complement activation on cell surfaces]
Z Med Mikrobiol Immunol. 1971;156(3):272-83. German.
136. Falke D, Rada B.
6-Azauridine as an inhibitor of the synthesis of Herpesvirus hominis.
Acta Virol. 1970 Mar;14(2):115-23.
137. Falke D.
[Reciprocal dissociativity of DNA synthesis and giant cell formation in
Herpesvirus hominis caused by cytosine arabinoside and compound 48-80]
Zentralbl Bakteriol [Orig]. 1970;212(2):390-4. German..
138. Falke D, Kahl GF.
[Inhibition of giant cell formation by compound 48-80 after infection with
Herpesvirus hominis. II. The activation of lysosomes]
Arch Gesamte Virusforsch. 1970;30(4):353-66. German.
139. Falke D.
[Recent data on the development of virus-induced tumors]
Dtsch Med Wochenschr. 1969 Jan 31;94(5):232-6. Review. German.
140. Falke D, Netter KJ.
[Inhibition of giant cell formation with the so-called Compound 48-80 after
infection with Herpesvirus hominis]
Arch Gesamte Virusforsch. 1969;28(3):308-24. German.
141. Falke D, Bitter-Suermann D, Clauss I.
[Giant cell formation and virus-specific antigens of herpesvirus hominis:
information flow from the parental DNA]
Arch Gesamte Virusforsch. 1969;27(2):317-31. German.
142. Peterknecht W, Bitter-Suermann D, Falke D.
[Immuneadherence as an assay for antibodies and antigens. II.
Immuneadherence-hemadsorption as an assay for cell and specific antigens on
culture cells]
Z Med Mikrobiol Immunol. 1968;154(3):234-44. German.
143. Falke D, Peterknecht W.
[Autoradiographic observations on the uptake of 3H-uridine in herpes-induced
giant cells]
Arch Gesamte Virusforsch. 1968;24(3):288-91. German.
144. Peterknecht W, Falke D.
Immune adherence assay of virus specific antigens and antibodies. I.
Elaboration of the method with Herpesvirus hominis and its serological
specificity]
Z Med Mikrobiol Immunol. 1968;154(2):132-44. German.
145. Falke D, Peterknecht W.
[DNA, RNA and protein synthesis and their relation to the formation of giant
cells in vitro after infection with herpesvirus hominis]
Arch Gesamte Virusforsch. 1968;24(3):267-87. German.
146. Falke D, Schiefer HG, Stoffel W.
[Lipoid analyses in giant cell formation by herpesvirus hominis]
Z Naturforsch B. 1967 Dec;22(12):1360-2. German.
147. Falke D.
Syncytienbildung bei Herpesvirus hominis.
Zentralbl f Bakteriol Parasitenk Infektionskrankh u Hygiene. 1967;205:160-4
148. Falke D.
[Ca++, histidine, and Zn++ as factors in the formation of giant cells by
herpesivirus hominis]
Z Med Mikrobiol Immunol. 1967;153(3):175-89. German.
149. Siegert R, Falke D.
[Electron microscopic studies on the development of Herpesvirus hominis in
tissue
culture cells]
Arch Gesamte Virusforsch. 1966;19(2):230-49. German.
150. Falke D, Kohlhage H, Niessing K.
Die Wirkung von Actidion auf die Synthese des Herpes-simplex-Virus in
Kulturen verschiedener Zellarten.
Z. Naturforschg. 1966:21:447-53
151. Neubauer H, Falke D, Simonis C.
[The effect of actidione, actinomycin, puromycin and ribonucleic acid (RNA)
on a standardized Herpes keratitis in rabbits.]
Albrecht Von Graefes Arch Ophthalmol. 1965 May 13;168:256-63. German.
152. Falke D.
[Tumors caused by viruses.]
Dtsch Med Wochenschr. 1965 Mar 5;90:440-6. Review. German.
153. Falke D.
[Studies on the relations between giant cell formation and infectivity of
Herpes simplex virus.]
Arch Gesamte Virusforsch. 1965;15:387-401. German.
154. Falke D, Rowe WP.
[The interference between polyoma virus and vesicular stomatitis virus in
mice.]
Arch Gesamte Virusforsch. 1965;15:210-9. German.
155. Falke D, Rowe WP.
[Mouse disease due to vesicular stomatitis virus. II. Pathology of organ
lesions and the involvement of the central and peripheral nervous systems]
Arch Gesamte Virusforsch. 1965;17(5):560-76. German.
156. Falke D, Rowe WP.
[Mouse disease due to vesicular stomatitis virus. I. Spread of the virus
dependent on the age of the mouse]
Arch Gesamte Virusforsch. 1965;17(5):549-59. German.
157. Falke D.
[Investigations on the relationships between biological activity and
particle type in herpes simplex virus]
Arch Gesamte Virusforsch. 1965;15(5):625-39. German.
158. Falke D.
[On serologic relations of B-virus and Herpes simplex virus in complement
fixation reaction.]
Z Hyg Infektionskr. 1964 Dec 3;150:185-93. German.
159. Kohlhage H, Falke D.
[Inhibition of Herpes simplex virus propagarion by ribonucleic acids. (Short
Report)]
Arch Gesamte Virusforsch. 1964;14:404-9. German.
160. Falke D.
[Biological activity and particle form of the Herpes simplex virus after
density gradient centrifugation.]
Zentralbl Bakteriol [Orig]. 1963 Dec;191:247-52. German.
161. Falke D.
Dissoziation von Riesenzellbildung und Infektiosität des
Herpes-simplex-Virus unter dem Einfluß von p-Fluorphenylalanin.
Die Naturwissenschaften. 1963;50(14):507-9.
162. Falke D, Schmidt G
Riesenzelltypen durch Parainfluenza-Virus 3 Kulturzellen.
Zentralbl f Bakteriol Parasitenk Infektionskrankh u Hygiene. 1963;188:149-59
163. Falke, D.
Isolation of two variants with different cytopathic properties from a strain
of herpes B virus.
Virology. 1961 Aug;14:492-5.
164. Falke D, Richter IE.
Phasenkontrastmikroskopische Befunde zur Bildung mehrkerniger Kulturzellen.
Eine Mikrozeitrafferfilm-Analyse.
Protoplasma. 1961;54(1)27-34.
165. Falke D, Richter IE.
Über die Einwirkung von ECHO-12-Virus und Hemmstoffen der Eiweißsynthese auf
Zellkulturen.
Zentralbl f Bakteriol Parasitenk Infektionskrankh u Hygiene. 1961;183:283-93
166. Falke D, Richter IE.
[Microcinematographic studies on the formation of giant cells induced by
herpes B virus in tissue culture. II. Morphological behavior and movement of the
nucleus.]
Arch Gesamte Virusforsch. 1961;11:86-99. German.
167. Falke D, Richter IE.
[Microcinematographic studies on the formation of giant cells induced by
herpes B virus in tissue culture. I. Processes at the cell boundary and granule
movement.]
Arch Gesamte Virusforsch. 1961;11:73-85. German.
168. Falke D, Richter IE.
Die Mitose einer dreikernigen Kulturzelle.
Die Naturwissenschaften. 1961:46(13):487-489
169. Falke D.
Versuche zur Reinigung von S-Antigen des Tollwut-Virus.
Monatshefte f. Tierheilkunde. 1960;12(6):181-87.
170. Siegert R, Enders G, Falke D.
[Serological study of the epidemiology of influenza A2.]
Arch Hyg Bakteriol. 1960 Jun;144:234-48. German.
171. Siegert R, Falke D, Dietrich F, Friolet B.
[Influenza virus infections of type D Sendai in Germany.]
Dtsch Med Wochenschr. 1959 Apr 3;84(14):659-63. German.
172. Falke D, Siegert R, Vogell W.
[Electron microscopic findings on the problem of double membrane formation
in herpes simplex virus.]
Arch Gesamte Virusforsch. 1959;9:484-96. German.
173. Falke D.
[Cell affinity, immunity and pathogenesis in Theiler's disease of mice.]
Z Hyg Infektionskr. 1958;144(5):436-53. German.
174. Falke D.
[Observation on the incidence of giant and foam cells in normal monkey
kidney cell cultures.]
Zentralbl Bakteriol [Orig]. 1958 Jan;170(6-7):377-87. German.
175. Falke D.
Über die Züchtung des Theiler-T0-Virus in der Gewebekultur.
Zeitschr. F. Hygiene. 1957; 143:645-55
176. Uhlmann W, Falke D.
Die Differenzierung der Negri-Körperchen im gefärbten Präparat mit Hilfe des
Phasenkontrastmikroskops.
Tierärztliche Wochenschrift. 1957; 70(17):365-6
177. Falke D, Uhlmann W.
Zur Frage der serologischen Tollwutdiagnose mit Hilfe des
Komplement-Bindungs-Testes.
Monatshefte f. Tierheilkunde. 1957;9(8):243-54.
Links
onmousedown="ET_Event.link('Link%20auf%20www.gaebler.info',